Examination of phenotypic changes in peripheral blood-derived dendritic cells following exposure to a contact allergen: Cell surface marker and gene expression

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 23, Issue 2, 2004, Pages 91-104

  Ryan, Cindy A ^a   Hulette, Ben C ^a   Gildea, Lucy A ^a   Dearman, Rebecca J ^b   Kimber, Ian ^b   Gerberick, G Frank ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Cell surface markers; Dendritic cells; Gene expression; In vitro alternatives; Skin sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; B7 ANTIGEN; BENZENESULFONIC ACID DERIVATIVE; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CONTACT ALLERGEN; DINITROBENZENESULFONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; RNA; T6 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LOCAL LYMPH NODE ASSAY; PERIPHERAL BLOOD DERIVED DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREDICTION; RISK ASSESSMENT; SKIN ALLERGY; SKIN SENSITIZATION;

ANIMALIA; MURINAE;

EID: 2542566442     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.1081/CUS-120030167     Document Type: Article

References (31)

1. Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF. The local lymph node assay: past, present and future. Contact Dermatitis 2002; 47:315-328.
2. Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG. Contact allergenic potency: correlation of human and local lymph node assay data. Am J Contact Dermat 2001; 12:156-161.
3. Basketter DA, Blaikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJG. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 2000; 42:344-348.
4. Ryan CA, Hulette BC, Gerberick GF. Approaches for the development of cell-based in vitro methods for contact sensitization. Toxicol In Vitro 2001; 15:43-55.
5. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of costimulatory molecules. Eur J Immunol 1997; 27:3031-3038.
6. Coutant KD, de Brugerolle de Fraissinette A, Cordier A, Ulrich P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sci 1999; 52:189-198.
7. 2 and SDS. Toxicol In Vitro 2001; 15:319-325.
8. Tuschl H, Kovac R, Weber E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol In Vitro 2000; 14:541-549.
9. Arrighi J-F, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J Immunol 2001; 166:3837-3845.
10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
11. Hulette BC, Ryan CA, Gerberick GF. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol Appl Pharmacol 2002; 182:226-233.
12. Hulette B, Gilmour N, Ryan C, Basketter D, Gerberick F. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergens. Toxicologist 2003; 72:54.
13. Ozawa H, Nakagawa S, Tagami H, Aiba S. Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturity differently. J Invest Dermatol 1996; 106:441-445.
14. Rattis FM, Peguet-Navarro J, Staquet MJ, Dezutter-Dambuyant C, Courtellemont P, Redziniak G, Schmitt D. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol 1996; 26:449-453.
15. Yokozeki H, Katayama I, Ohki O, Matsunaga T, Watanabe K, Satoh T, Azuma M, Okumura K, Nishioka K. Functional CD86 (B7-2/B70) on cultured human Langerhans cells. J Invest Dermatol 1996; 106:147-153.
16. Nuriya S, Yagita H, Okumura K, Azuma M. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and effector phases of contact hypersensitivity. Int Immunol 1996; 8:917-926.
17. Katayama I, Matsunaga T, Yokozeki H, Nishioka K. Blockade of co-stimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells. Br J Dermatol 1997; 136:846-852.
18. Ashikaga T, Hoya M, Itagaki H, Katsumura K, Aiba S. Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 2002; 16:711-716.
19. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145:2833-2838.
20. Ma J, Wang JH, Guo YJ, Sy MS, Bigby M. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol 1994; 158:389-399.
21. Xu H, Guan H, Zu G, Bullard D, Hanson J, Slater M, Elmets CA. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol 2001; 31:3085-3093.
22. Moodycliffe AM, Shreedhar V, Ullrich SE, Walterscheid J, Bucana C, Kripke ML, Flores-Romo L. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 2000; 191:2011-2020.
23. Jolles S, Christensen J, Holman M, Klaus GB, Ager A. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin. Clin Exp Immunol 2002; 129:519-526.
24. Stoitzner P, Holzmann S, McLellan AD, Ivarrson L, Stössel H, Kapp M, Kämmerer U, Douillard P, Kämpgen E, Koch F, Saeland S, Romani N. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 2003; 120:266-274.
25. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27:3135-3142.
26. Messmer D, Messmer B, Chiorazzi N. The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. Int Immunol 2003; 15:491-503.
27. Tuschl H, Kovac R. Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol In Vitro 2001; 15:327-331.
28. Rougier N, Redziniak G, Mougin D, Schmitt D, Vincent C. In vitro evaluation of the sensitization potential of weak-contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 2000; 145:7-82.
29. + T cells. J Immunol 1999; 163:3597-3604.
30. Salamero J, Bausinger H, Mommaas AM, Lipsker D, Proamer F, Cazenave J-P, Goud B, de la Salle H, Hanau D. CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. J Invest Dermatol 2001; 116:401-408.
31. Rambukkana A, Pistoor FHM, Bos JD, Kapsenberg ML, Das PK. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1β protein. Lab Invest 1996; 74:422-436.